nidagyl 500mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - metronidazole - capsule,hard - 500mg - metronidazole (0000443481) 500mg - metronidazole
flecoxin 8mg tablets
remedica ltd (0000003171) aharnon str., lemesos, 3056 - bromhexine hydrochloride - tablets - 8mg - bromhexine hydrochloride (0000611756) 8mg - bromhexine
netin 100mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - gabapentin - capsule,hard - 100mg - gabapentin (0060142963) 100mg - gabapentin
netin 300mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - gabapentin - capsule,hard - 300mg - gabapentin (0060142963) 300mg - gabapentin
netin 400mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - gabapentin - capsule,hard - 400mg - gabapentin (0060142963) 400mg - gabapentin
tramadex 50mg capsule,hard
delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - tramadol hydrochloride - capsule,hard - 50mg - tramadol hydrochloride (0022204882) 50mg - tramadol
lipidil nt 145mg film coated tablets
viatris healthcare limited. (0000012172) damastown industrial park, mulhuddart, dublin 15, d15 xd71 - fenofibrate - film coated tablets - 145mg - fenofibrate (0049562289) 145mg - fenofibrate
newzypra or.disp.ta 5mg/tab
doc pharma ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ Δ.Τ. doc pharma ae Αγ. Γεωργίου 5, cosmos offices,, 570 01 Θεσσαλονίκη 23130.80720 - olanzapine - or.disp.ta (ΔΙΣΚΙΑ ΔΙΑΣΠΕΙΡΩΜΕΝΑ ΣΤΟ ΣΤΟΜΑ) - 5mg/tab - olanzapine 5mg - olanzapine
newzypra or.disp.ta 20mg/tab
doc pharma ΑΝΩΝΥΜΗ ΕΤΑΙΡΕΙΑ Δ.Τ. doc pharma ae Αγ. Γεωργίου 5, cosmos offices,, 570 01 Θεσσαλονίκη 23130.80720 - olanzapine - or.disp.ta (ΔΙΣΚΙΑ ΔΙΑΣΠΕΙΡΩΜΕΝΑ ΣΤΟ ΣΤΟΜΑ) - 20mg/tab - olanzapine 20mg - olanzapine
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - Εμβόλια - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.